-
Eldelumab (alternative
identifier BMS-936557) is a
fully human monoclonal antibody (type IgG1 kappa) that
targets chemokine (C-X-C motif)
ligand 10...
- (PF4) CXCL9 (MIG) CXCL10 (IP-10) CXCL11 (I-TAC)
Iroplact Antibodies:
Eldelumab (against CXCL10) CXCR4 Agonists: MIF SDF-1 (CXCL12)
Ubiquitin Antagonists:...
- (PF4) CXCL9 (MIG) CXCL10 (IP-10) CXCL11 (I-TAC)
Iroplact Antibodies:
Eldelumab (against CXCL10) CXCR4 Agonists: MIF SDF-1 (CXCL12)
Ubiquitin Antagonists:...
- (PF4) CXCL9 (MIG) CXCL10 (IP-10) CXCL11 (I-TAC)
Iroplact Antibodies:
Eldelumab (against CXCL10) CXCR4 Agonists: MIF SDF-1 (CXCL12)
Ubiquitin Antagonists:...
- migration)
Efungumab Mycograb scFv
human Hsp90
invasive Candida infection Eldelumab mab
human CXCL10 (IP-10) Crohn's disease,
ulcerative colitis Elezanumab...
- (PF4) CXCL9 (MIG) CXCL10 (IP-10) CXCL11 (I-TAC)
Iroplact Antibodies:
Eldelumab (against CXCL10) CXCR4 Agonists: MIF SDF-1 (CXCL12)
Ubiquitin Antagonists:...
- (PF4) CXCL9 (MIG) CXCL10 (IP-10) CXCL11 (I-TAC)
Iroplact Antibodies:
Eldelumab (against CXCL10) CXCR4 Agonists: MIF SDF-1 (CXCL12)
Ubiquitin Antagonists:...
- (PF4) CXCL9 (MIG) CXCL10 (IP-10) CXCL11 (I-TAC)
Iroplact Antibodies:
Eldelumab (against CXCL10) CXCR4 Agonists: MIF SDF-1 (CXCL12)
Ubiquitin Antagonists:...
- (PF4) CXCL9 (MIG) CXCL10 (IP-10) CXCL11 (I-TAC)
Iroplact Antibodies:
Eldelumab (against CXCL10) CXCR4 Agonists: MIF SDF-1 (CXCL12)
Ubiquitin Antagonists:...
- (PF4) CXCL9 (MIG) CXCL10 (IP-10) CXCL11 (I-TAC)
Iroplact Antibodies:
Eldelumab (against CXCL10) CXCR4 Agonists: MIF SDF-1 (CXCL12)
Ubiquitin Antagonists:...
